PiGe ll Real Skin Mask Pack
- Manufacturer
- Osung Co., Ltd | JT Co., Ltd
- Effective date
- 2013-01-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:34:15
Label at a glance#
ProductPiGe ll Real Skin Mask Pack
Active ingredientSUS SCROFA SKIN
Label structure8 sections
Label contents#
Full prescribing information#
pork skin
INACTIVE INGREDIENT SECTION
Water, Glycerin, Carrageenan, Ceratonia Siliqua Gum, Xanthan Gum, Butylene Glycol, Mineral Oil, Calcium Chloride, Etyl Alcohol, Lysine, Histidine, Arginine, Aspartic Acid, Threonine, Serine, Glutamic Acid, Proline, Glycine, Alanine, Valine, Methionine, Isoleucine, Leucine, Tyrosine, Phenylalanine, Cysteine, Hydrolyzed Collagen (0.1%), Coix Lacryma-Jobi Ma-yuen Seed Extract, Oryza Sativa (Rice) Bran Extract, Red Ginseng Extract, Argania Spinosa Kernel Oil, Adenosine, PEG-60 Hydrogenated Castor Oil, Disodium EDTA, Triethanolamine, Scutellaria Baicalensis Root Extract, Camellia Sinensis Leaf Extract, Houttuynia Cordata Extract, Artemisia Vulgaris Extract, Citrus Junos Fruit Extract, 1,2-Hexanediol, Caprylyl Glycol, Ethyl Hexanediol, Citrus Grandis (Grapefruit) Seed Extract, Bambusa Textilis Stem Extract, Pinus Palustris Leaf Extract, Propylparaben, Ethylparaben, Butylparaben, Isobutylparaben, Phenoxyethanol, Methylparaben, Chlorphenesin, Fragrance
OTC - PURPOSE SECTION
for the treatment of skin
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out or reach of the children
INDICATIONS & USAGE SECTION
attach biogel sheets to fit your face (upper sheet with eyes as the center, lower sheet with lips as the center)
WARNINGS SECTION
■ Avoid using on blemishes, pimples, irritated or sunburned skin.
■ Avoid using on skin which is sensitive to bandages, tapes or peel-off masks.
■ Stop using if skin becomes reddish, swollen or itchy, during and after usage.
■ Avoid contact with eyes directly.
■ Avoid using on skin which is sensitive to bandages, tapes or peel-off masks.
■ Stop using if skin becomes reddish, swollen or itchy, during and after usage.
■ Avoid contact with eyes directly.
DOSAGE & ADMINISTRATION SECTION
for external use only
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| SUS SCROFA SKIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20181113 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2 | Product name | 5 | 20250304 |
| 2e254488-9fcb-41b3-a7c3-e2c9a3941b29 | Product name | 1 | 20200603 |
| b4ff0805-126a-406d-9cae-fc34fd8e8889 | Product name | 1 | 20190711 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| 87711080-88eb-65c5-b2dd-bf99e700a372 | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55282-1001-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e7b9-cd31-e053-dbdaa90ab51a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55282-1001-1 | PiGe ll Real Skin Mask Pack | 35 g in 1 PACKAGE | LIQUID | 35 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55282-1001 | PIGE LL REAL SKIN MASK PACK (SUS SCROFA SKIN) LIQUID [OSUNG CO., LTD] | 1 | Legacy NDC, 1 package rows | 20130114_13213a12-0a9b-4179-8da5-ae7e5ef4c3f7.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SUS SCROFA SKIN | ACTIVE INGREDIENT | 3EM4VW6TQN | 1 | |
| SUS SCROFA SKIN | ACTIVE MOIETY | 3EM4VW6TQN | 1 | |
| 1,2-HEXANEDIOL | INACTIVE INGREDIENT | TR046Y3K1G | 1 | |
| ADENOSINE | INACTIVE INGREDIENT | K72T3FS567 | 1 | |
| ALANINE | INACTIVE INGREDIENT | OF5P57N2ZX | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| ARGAN OIL | INACTIVE INGREDIENT | 4V59G5UW9X | 1 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 1 | |
| ARTEMISIA VULGARIS ROOT | INACTIVE INGREDIENT | 32MP823R8S | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | 1 | |
| BAMBUSA TEXTILIS STEM | INACTIVE INGREDIENT | 7L05M929Y1 | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| CALCIUM CHLORIDE | INACTIVE INGREDIENT | M4I0D6VV5M | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CARRAGEENAN | INACTIVE INGREDIENT | 5C69YCD2YJ | 1 | |
| CERATONIA SILIQUA WHOLE | INACTIVE INGREDIENT | 12640NNX2M | 1 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| CITRUS JUNOS FRUIT | INACTIVE INGREDIENT | 53KHW58C1V | 1 | |
| CITRUS MAXIMA SEED | INACTIVE INGREDIENT | 083X55C543 | 1 | |
| COIX LACRYMA-JOBI SEED OIL | INACTIVE INGREDIENT | 271N0Q057Z | 1 | |
| CYSTEINE | INACTIVE INGREDIENT | K848JZ4886 | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| ETHOHEXADIOL | INACTIVE INGREDIENT | M9JGK7U88V | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GLUTAMIC ACID | INACTIVE INGREDIENT | 3KX376GY7L | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 1 | |
| HISTIDINE | INACTIVE INGREDIENT | 4QD397987E | 1 | |
| HOUTTUYNIA CORDATA FLOWERING TOP | INACTIVE INGREDIENT | RH041UUZ22 | 1 | |
| ISOBUTYLPARABEN | INACTIVE INGREDIENT | 0QQJ25X58G | 1 | |
| ISOLEUCINE | INACTIVE INGREDIENT | 04Y7590D77 | 1 | |
| LEUCINE | INACTIVE INGREDIENT | GMW67QNF9C | 1 | |
| LYSINE | INACTIVE INGREDIENT | K3Z4F929H6 | 1 | |
| METHIONINE | INACTIVE INGREDIENT | AE28F7PNPL | 1 | |
| METHYLISOTHIAZOLINONE | INACTIVE INGREDIENT | 229D0E1QFA | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 1 | |
| ORYZA SATIVA WHOLE | INACTIVE INGREDIENT | 84IVV0906Z | 1 | |
| PANAX GINSENG ROOT OIL | INACTIVE INGREDIENT | P9T4K47OM0 | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PHENYLALANINE | INACTIVE INGREDIENT | 47E5O17Y3R | 1 | |
| PINUS PALUSTRIS LEAF | INACTIVE INGREDIENT | OT6R5143A1 | 1 | |
| POLYOXYL 60 HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | 02NG325BQG | 1 | |
| PROLINE | INACTIVE INGREDIENT | 9DLQ4CIU6V | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SCUTELLARIA BAICALENSIS ROOT | INACTIVE INGREDIENT | 7J95K7ID2S | 1 | |
| SERINE | INACTIVE INGREDIENT | 452VLY9402 | 1 | |
| TEA LEAF OIL | INACTIVE INGREDIENT | VC855RRT77 | 1 | |
| THREONINE | INACTIVE INGREDIENT | 2ZD004190S | 1 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| TYROSINE | INACTIVE INGREDIENT | 42HK56048U | 1 | |
| VALINE | INACTIVE INGREDIENT | HG18B9YRS7 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- PiGe ll Real Skin Mask Pack
- SUS SCROFA SKIN
- METHYLISOTHIAZOLINONE
- WATER
- GLYCERIN
- CARRAGEENAN
- CERATONIA SILIQUA WHOLE
- XANTHAN GUM
- BUTYLENE GLYCOL
- MINERAL OIL
- CALCIUM CHLORIDE
- ALCOHOL
- LYSINE
- HISTIDINE
- ARGININE
- ASPARTIC ACID
- THREONINE
- SERINE
- GLUTAMIC ACID
- PROLINE
- GLYCINE
- ALANINE
- VALINE
- METHIONINE
- ISOLEUCINE
- LEUCINE
- TYROSINE
- PHENYLALANINE
- CYSTEINE
- COIX LACRYMA-JOBI SEED OIL
- ORYZA SATIVA WHOLE
- PANAX GINSENG ROOT OIL
- ARGAN OIL
- ADENOSINE
- POLYOXYL 60 HYDROGENATED CASTOR OIL
- EDETATE DISODIUM
- TROLAMINE
- SCUTELLARIA BAICALENSIS ROOT
- TEA LEAF OIL
- HOUTTUYNIA CORDATA FLOWERING TOP
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55282-1001 | 55282-1001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HISTIDINE | HISTIDINE | 4QD397987E | INJECTION / INTRAVENOUS | 465 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION / INTRAVENOUS | 790 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SUBCUTANEOUS | 22 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY / NASAL | 1 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 2350 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / OPHTHALMIC | 2 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOLUTION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| ASPARTIC ACID | ASPARTIC ACID | 30KYC7MIAI | INJECTION / INTRAVENOUS | 22 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EFFERVESCENT / ORAL | 32 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / AURICULAR (OTIC) | 0.1 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, COATED / ORAL | 0.8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET / ORAL | 163.31 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| CARRAGEENAN | CARRAGEENAN | 5C69YCD2YJ | CAPSULE, DELAYED RELEASE / ORAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / ORAL | 4 mg | ||
| PHENYLALANINE | PHENYLALANINE | 47E5O17Y3R | INJECTION / INTRAVENOUS | 7.26 mg | ||
| SERINE | SERINE | 452VLY9402 | INJECTION, SOLUTION / INTRAVENOUS | 0.18 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / OPHTHALMIC | 0.6 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SPRAY / TOPICAL | 0.2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| METHIONINE | METHIONINE | AE28F7PNPL | INJECTION / INTRAVENOUS | 16 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| LEUCINE | LEUCINE | GMW67QNF9C | INJECTION / INTRAVENOUS | 1.1 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | 45 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | CREAM / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL, METERED / TOPICAL | 20 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION/ DROPS / OPHTHALMIC | 0.01 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / TOPICAL | 0.1 %w/w | ||
| GLYCINE | GLYCINE | TE7660XO1C | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| THREONINE | THREONINE | 2ZD004190S | INJECTION / INTRAVENOUS | 0.45 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | ||
| SERINE | SERINE | 452VLY9402 | INJECTION / INTRAVENOUS | 0.5 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SYRUP / ORAL | 40 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| PROLINE | PROLINE | 9DLQ4CIU6V | INJECTION, SOLUTION / INTRAVENOUS | 0.34 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | ENEMA / RECTAL | 150 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a7e18cae-73f6-4c8c-8be8-19c75f087af4 | 13213a12-0a9b-4179-8da5-ae7e5ef4c3f7 | 2013-01-14 | Warnings | a7e18cae-73f6-4c8c-8be8-19c75f087af4 13213a12-0a9b-4179-8da5-ae7e5ef4c3f7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
